3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
240
INDUSTRY
201
NIH
65
NETWORK
10
OTHER_GOV
2
FED
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
7
Gynecologic
4
Other hematologic neoplasm
2
Genitourinary
2
Tumor-Agnostic
1
Sarcoma
1
Lymphoid
1
Dermatologic
1
Breast
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Adenocarcinoma
1
Interventions
darolutamide
1
Mitomycin
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Genitourinary
×
30 days
×
Clear all
NCT07617272
2026-06-01
PARIS-BIO
Region Stockholm
Phase 2
Recruiting
100 enrolled
NCT06388720
2026-05-29
IMGeS
National Cancer Center, Korea
Phase 2
Recruiting
82 enrolled